Twinbeech Capital LP Global Blood Therapeutics, Inc. Transaction History

Twinbeech Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$22.3 - $37.39 $1.26 Million - $2.11 Million	-56,322 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $193,704 - $268,455	7,543 Added 15.46%	56,322 $1.95 Million
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $517,098 - $836,079	20,767 Added 74.14%	48,779 $1.43 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $713,745 - $1.05 Million	28,012 New	28,012 $714,000
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $486,852 - $824,609	-12,931 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$52.76 - $74.49 $682,239 - $963,230	12,931 New	12,931 $713,000
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $107,220 - $224,104	-2,570 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $117,449 - $210,380	2,570 New	2,570 $204,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.